Prevalence of endoscopic improvement and remission according to patient-reported outcomes in ulcerative colitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prevalence of endoscopic improvement and remission according to patient-reported outcomes in ulcerative colitis

Published:2019-11-22 Issue:4 Volume:51 Page:435-445
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Dulai Parambir S.¹^ORCID,Singh Siddharth¹^ORCID,Jairath Vipul²,Ma Christopher³^ORCID,Narula Neeraj⁴^ORCID,Vande Casteele Niels¹^ORCID,Peyrin-Biroulet Laurent⁵^ORCID,Vermeire Severine⁶,D’Haens Geert⁷,Feagan Brian G.²^ORCID,Sandborn William J.¹^ORCID

Affiliation:

1. Division of Gastroenterology; Department of Medicine; University of California San Diego; La Jolla CA USA

2. Department of Medicine; University of Western Ontario; London ON Canada

3. Division of Gastroenterology and Hepatology; University of Calgary; Calgary Alberta Canada

4. Division of Gastroenterology; McMaster University; Hamilton Ontario Canada

5. Nancy University Hospital; Nancy France

6. Division of Gastroenterology; University Hospitals Leuven; Leuven Belgium

7. Department of Internal Medicine; Academic Medical Center; Amsterdam The Netherlands

Funder

American Gastroenterology Association

American College of Gastroenterology

Crohn's and Colitis Foundation

National Institute of Diabetes and Digestive and Kidney Diseases

McMaster University

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15577/fullpdf

Reference27 articles.

1. Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target;Peyrin-Biroulet;Am J Gastroenterol,2015

2. Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials;Jairath;Aliment Pharmacol Ther,2015

3. Patient-reported outcomes and endoscopic appearance of ulcerative colitis-a systematic review and meta-analysis;Narula;Clin Gastroenterol Hepatol,2019

4. Clinical parameters correlate with endoscopic activity of ulcerative colitis: a systematic review;Restellini;Clin Gastroenterol Hepatol,2019

5. Safety of infliximab: primum non nocere. The safety profile of infliximab in patients with Crohn's disease: the Mayo Clinic experience in 500 patients;Parsi;Inflamm Bowel Dis,2004

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using Computer Vision to Improve Endoscopic Disease Quantification in Therapeutic Clinical Trials of Ulcerative Colitis;Gastroenterology;2024-01

2. AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Crohn’s Disease;Gastroenterology;2023-12

3. Early recapture of response with tofacitinib 10 mg twice daily in patients with ulcerative colitis in OCTAVE Open following dose reduction or treatment interruption in OCTAVE Sustain;Journal of Gastroenterology and Hepatology;2023-11-12

4. Real-world long-term effectiveness of ustekinumab in ulcerative colitis: results from a spanish open-label cohort;Scandinavian Journal of Gastroenterology;2023-11-06

5. Common Instances of Low-value Care in Inflammatory Bowel Diseases;Clinical Gastroenterology and Hepatology;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3